Most Recent Additions

PDF

Pan-squamous genomic profiling stratified by anatomic tumor site and viral association
M. Montesion, C. H. Chung, E. S. Sokol, S. A. Khan, H. Kang, L. A. Albacker, J. M. Johnson, G. M. Frampton, V. A. Miller, J. S. Ross, and S. M. Ali

PDF

Tailored for Real-World: A Whole Slide Image Classification System Validated on Uncurated Multi-Site Data Emulating the Prospective Pathology Workload.
Julianna D. Ianni, Rajath E. Soans, Sivaramakrishnan Sankarapandian, Ramachandra Vikas Chamarthi, Devi Ayyagari, Thomas G. Olsen, Michael J. Bonham, Coleman C. Stavish, Kiran Motaparthi, Clay J. Cockerell, Theresa A. Feeser, and Jason B. Lee

PDF

Synthetic DNA immunotherapy in biochemically relapsed prostate cancer
N. Shore, E. I. Heath, L. T. Nordquist, H. Cheng, K. Bhatt, M. Morrow, T. McMullan, K. Kraynyak, J. Lee, B. Sacchetta, L. Liu, S. Rosencranz, S. T. Tagawa, L. J. Appleman, R. Tutrone, J. Garcia, Y. Whang, W. Kelly, I. Csiki, and M. L. Bagarazzi

PDF

First Pass Effect in Patients Treated With the Trevo Stent-Retriever: A TRACK Registry Study Analysis.
Maxim Mokin, Christopher T. Primiani, Alicia C. Castonguay, Raul G. Nogueira, Diogo C. Haussen, Joey D. English, Sudhakar R. Satti, Jennifer Chen, Hamed Farid, Candace Borders, Erol Veznedaroglu, Mandy J. Binning, Ajit Puri, Nirav A. Vora, Ron F. Budzik, Guilherme Dabus, Italo Linfante, Vallabh Janardhan, Amer Alshekhlee, Michael G. Abraham, Randall Edgell, Muhammad Asif Taqi, Ramy El Khoury, Anie Q. Majjhoo, Mouhammed R. Kabbani, Michael T. Froehler, Ira Finch, Sameer A. Ansari, Roberta Novakovic, Thanh N. Nguyen, and Osama O. Zaidat

PDF

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
Deli Liu, Mandeep Takhar, Mohammed Alshalalfa, Nicholas Erho, Jonathan Shoag, Robert B. Jenkins, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Mark A. Rubin, Bruce Trock, Eric A. Klein, Robert B. Den, Scott A. Tomlins, Daniel E. Spratt, Elai Davicioni, Andrea Sboner, and Christopher E. Barbieri

PDF

NCI-MATCH Arms N & P: Phase II study of PI3K beta inhibitor GSK2636771 in patients (pts) with cancers (ca) with PTEN mutation/deletion (mut/del) or PTEN protein loss
F. Janku, O. Jegede, S. L. Puhalla, P. Konstantinopoulos, F. Meric-Bernstam, E. P. Mitchell, J. A. Zwiebel, L. M. McShane, S. Li, L. V. Rubinstein, L. A. Doyle, D. Patton, B. A. Conley, P. J. O'Dwyer, L. N. Harris, C. Arteaga, P. M. Williams, S. R. Hamilton, A. P. Chen, and K. T. Flaherty

PDF

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
U. N. Lassen, C. M. Albert, S. Kummar, C. M. van Tilburg, S. G. Dubois, B. Geoerger, L. Mascarenhas, N. Federman, R. J. Schilder, F. Doz, J. D. Berlin, D. Y. Oh, S. S. Bielack, R. McDermott, D. S. Tan, S. Cruickshank, N. C. Ku, M. C. Cox, A. Drilon, and D. S. Hong

PDF

Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer.
Priyanga Selvakumar, Aja Badgeley, Paige Murphy, Hina Anwar, Urvashi Sharma, Katharine Lawrence, and Ashakumary Lakshmikuttyamma

PDF

Utilizing Digital Health to Collect Electronic Patient-ReportedOutcomes in Prostate Cancer: Single-Arm Pilot Trial
Christine Tran, MS; Adam Dicker, MD, PhD; Benjamin Leiby, PhD; Eric Gressen, MD; Noelle Williams, MD; and Heather Jim, PhD

PDF

Disruptive Effects of the Coronavirus – Errors of Commission and of Omission?
John Pourdehnad, Larry M. Starr, Venard Scott Koerwer, and Harry McCloskey

PDF

Our Wicked Problem
John Pourdehnad, Larry M. Starr, Venard Scott Koerwer, and Harry McCloskey

PDF

Smart Rooms Devices as a Modality of Enhancing Patient Engagement
Daniel Campbell; Alison Romisher; Thomas Hurysz; Maia Ottenstein; and Anna Marie Chang, MD

PDF

Evaluating the Impact of KardiaMobile on Healthcare Expenditures
Christopher Gerace, MPH and Daniel Frisch, MD

*Updated as of 03/28/20.